Safety of Stress Cardiac Magnetic Resonance in Patients With Moderate to Severe Aortic Valve Stenosis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND: Dobutamine and adenosine stress cardiac magnetic resonance (CMR) imaging is relatively contraindicated in patients with moderate to severe aortic valve stenosis (AS). We aimed to determine the safety of dobutamine and adenosine stress CMR in patients with moderate to severe AS. METHODS: In this retrospective study patients with AS who underwent either dobutamine or adenosine stress CMR for exclusion of obstructive coronary artery disease were enrolled. We recorded clinical data, CMR and echocardiography findings, and complications as well as minor symptoms. Patients with AS were compared to matched individuals without AS. RESULTS: A total of 187 patients with AS were identified and compared to age-, gender- and body mass index-matched 187 patients without AS. No severe complications were reported in the study nor the control group. The reported frequency of non-severe complications and minor symptoms were similar between the study and the control groups. Nineteen patients with AS experienced non-severe complications or minor symptoms during dobutamine stress CMR compared to eighteen patients without AS (p = 0.855). One patient with AS and two patients without AS undergoing adenosine stress CMR experienced minor symptoms (p = 0.562). Four examinations were aborted because of chest pain, paroxysmal atrial fibrillation and third-degree atrioventricular block. Inducible ischaemia, prior coronary artery bypass grafting, prior stroke and age were associated with a higher incidence of complications and minor symptoms. CONCLUSIONS: Moderate to severe AS was not associated with complications during CMR stress test. The incidence of non-severe complications and minor symptoms was greater with dobutamine.
Abstract
BACKGROUND: Dobutamine and adenosine stress cardiac magnetic resonance (CMR) imaging is relatively contraindicated in patients with moderate to severe aortic valve stenosis (AS). We aimed to determine the safety of dobutamine and adenosine stress CMR in patients with moderate to severe AS. METHODS: In this retrospective study patients with AS who underwent either dobutamine or adenosine stress CMR for exclusion of obstructive coronary artery disease were enrolled. We recorded clinical data, CMR and echocardiography findings, and complications as well as minor symptoms. Patients with AS were compared to matched individuals without AS. RESULTS: A total of 187 patients with AS were identified and compared to age-, gender- and body mass index-matched 187 patients without AS. No severe complications were reported in the study nor the control group. The reported frequency of non-severe complications and minor symptoms were similar between the study and the control groups. Nineteen patients with AS experienced non-severe complications or minor symptoms during dobutamine stress CMR compared to eighteen patients without AS (p = 0.855). One patient with AS and two patients without AS undergoing adenosine stress CMR experienced minor symptoms (p = 0.562). Four examinations were aborted because of chest pain, paroxysmal atrial fibrillation and third-degree atrioventricular block. Inducible ischaemia, prior coronary artery bypass grafting, prior stroke and age were associated with a higher incidence of complications and minor symptoms. CONCLUSIONS: Moderate to severe AS was not associated with complications during CMR stress test. The incidence of non-severe complications and minor symptoms was greater with dobutamine.
참고문헌 (30)
- Nagel E, "Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI : comparison with dobutamine stress echocardiography", Circulation, 99, pp.763~770 (1999)
- Kelle S, "A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3, 138 consecutive patients", J Am Coll Cardiol, 61, pp.2310~2312 (2013)
- Hamon M, "Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease", J Cardiovasc Magn Reson, 12, pp.29~ (2010)
- Nagel E, "Magnetic resonance perfusion or fractional flow reserve in coronary disease", N Engl J Med, 380, pp.2418~2428 (2019)
- Wahl A, "Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia : experience in 1000 consecutive cases", Eur Heart J, 25, pp.1230~1236 (2004)
- Lattanzi F, "Dobutamine stress echocardiography : safety in diagnosing coronary artery disease", Drug Saf, 22, pp.251~262 (2000)
- Wilson RF, "Effects of adenosine on human coronary arterial circulation", Circulation, 82, pp.1595~1606 (1990)
- Khoo JP, "Stress cardiovascular MR in routine clinical practice : referral patterns, accuracy, tolerance, safety and incidental findings", Br J Radiol, 85, pp.e851~e857 (2012)
- Karamitsos TD, "Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance", J Cardiovasc Magn Reson, 12, pp.66~ (2010)
- Adler Y, "Nonobstructive aortic valve calcification : a window to significant coronary artery disease", Atherosclerosis, 161, pp.193~197 (2002)
- Rapp AH, "Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris", Am J Cardiol, 87, pp.1216~1217 (2001)
- Henzlova MJ, "ASNC imaging guidelines for SPECT nuclear cardiology procedures : stress, protocols, and tracers", J Nucl Cardiol, 23, pp.606~639 (2016)
- Bountioukos M, "Safety of dobutamine stress echocardiography in patients with aortic stenosis", J Heart Valve Dis, 12, pp.441~446 (2003)
- Mubagwa K, "Role of adenosine in the heart and circulation", Cardiovasc Res, 32, pp.797~813 (1996)
- Kramer CM, "Standardized cardiovascular magnetic resonance imaging(CMR)protocols : 2020 update", J Cardiovasc Magn Reson, 22, pp.17~ (2020)
- Knuuti J, "The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina : a meta-analysis focused on post-test disease probability", Eur Heart J, 39, pp.3322~3330 (2018)
- Baumgartner H, "Recommendations on the echocardiographic assessment of aortic valve stenosis : a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography", Eur Heart J Cardiovasc Imaging, 18, pp.254~275 (2017)
- aus dem Siepen F, "T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance : quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy", Eur Heart J Cardiovasc Imaging, 16, pp.210~216 (2015)
- Riffel JH, "Cardiovascular magnetic resonance of cardiac morphology and function : impact of different strategies of contour drawing and indexing", Clin Res Cardiol, 108, pp.411~429 (2019)
- Biglands JD, "Cardiovascular magnetic resonance physics for clinicians : Part II", J Cardiovasc Magn Reson, 14, pp.66~ (2012)
- Korosoglou G, "Strain-encoded cardiac MRI as an adjunct for dobutamine stress testing: incremental value to conventional wall motion analysis", Circ Cardiovasc Imaging, 2, pp.132~140 (2009)
- Kramer CM, "Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update", J Cardiovasc Magn Reson, 15, pp.91~ (2013)
- Nandalur KR, "Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease : a meta-analysis", J Am Coll Cardiol, 50, pp.1343~1353 (2007)
- El Aidi H, "Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease : a systematic review of prognostic studies", J Am Coll Cardiol, 63, pp.1031~1045 (2014)
- Robbers-Visser D, "Safety and observer variability of cardiac magnetic resonance imaging combined with low-dose dobutamine stress-testing in patients with complex congenital heart disease", Int J Cardiol, 147, pp.214~218 (2011)
- Ripley DP, "Safety and feasibility of dobutamine stress cardiac magnetic resonance for cardiovascular assessment prior to renal transplantation", J Cardiovasc Med(Hagerstown), 15, pp.288~294 (2014)
- Monmeneu Menadas JV, "Pharmacological stress cardiovascular magnetic resonance : feasibility and safety in a large multicentre prospective registry", Eur Heart J Cardiovasc Imaging, 17, pp.308~315 (2016)
- Reisenhofer B, "Cardiac rupture during dobutamine stress test", Ann Intern Med, 128, pp.605~ (1998)
- Datino T, "Cardiac rupture during contrast-enhanced dobutamine stress echocardiography", Int J Cardiol, 98, pp.349~350 (2005)
- Ahn JH, "Coronary microvascular dysfunction as a mechanism of angina in severe AS : prospective adenosine-stress CMR study", J Am Coll Cardiol, 67, pp.1412~1422 (2016)